Recombinant Human SH3BGRL2 protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human SH3BGRL2 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 107 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
FASH3, SH3BGRL2, SH3 domain-binding glutamic acid-rich-like protein 2, Fovea-associated SH3 domain-binding protein
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human SH3BGRL2 protein (His tag N-Terminus) (AB134519)
15% SDS-PAGE analysis of ab134519 (3ug)
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of SH3BGRL2 includes participating in signaling cascades. It does not exist as part of a major known complex but likely influences these cascades by modulating the activity of proteins with SH3 domains. This interaction facilitates various cellular processes demonstrating its importance in cellular functionality and response.
Pathways
The involvement of SH3BGRL2 extends to important signaling processes like the MAPK/ERK pathway. By modulating proteins such as growth factor receptor-bound protein 2 (Grb2) SH3BGRL2 impacts cell proliferation and differentiation. Another related pathway is the JNK signaling pathway where similar interactions may influence apoptotic processes linking SH3BGRL2 to cellular survival and stress responses.
Specifications
Form
Liquid
Additional notes
ab134519 was purified using conventional chromatography techniques.
General info
Sequence similarities
Belongs to the SH3BGR family.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com